Volume 197, Issue 3 , Pages 244.e1-244.e8, September 2007
Angiogenic factors for the prediction of preeclampsia in high-risk women
To access this article, please choose from the options below
This work was supported in part by the Departments of Medicine and Obstetrics and Gynecology, University of Massachusetts Medical School/UMass Memorial Health Care. S.E.M. is named as a coinventor on a patent filed by Beth Israel Deaconess Medical Center for the use of angiogenesis-related proteins for diagnosis and treatment of preeclampsia.
Cite this article as: Moore Simas TA, Crawford SL, Solitro MJ, et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007;197:244.e1-244.e8.
PII: S0002-9378(07)00759-4
doi:10.1016/j.ajog.2007.06.030
© 2007 Mosby, Inc. All rights reserved.
Volume 197, Issue 3 , Pages 244.e1-244.e8, September 2007
